S2
A (0.1% NH 4 OH in water) and B (0.1% NH 4 OH in methanol): 65% B increasing to 100% B over 30 min., isocratic at 100% B for 1 min. before returning to 65%B and re-equilibrating over 3 min. High resolution mass spectrometry (HRMS) was carried out by Ted Voss at the WM Keck Foundation Biotechnology Resource Laboratory at Yale University on a Bruker 9.4T FT-ICR MS. Infrared (IR) spectra are recorded on a Perkin Elmer 781 spectrophotometer, λ max in cm -1 . Bands are characterized as broad (br), strong (s), medium (m) or weak (w). 1 H NMR spectra were recorded on a Varian Unity 600 MHz spectrometer. Chemical shifts are reported in ppm from tetramethylsilane with the solvent resonance resulting from incomplete deuteration as the internal standard (CDCl 3 : δ 7.26, CD 3 OD: δ 3.31, DMSO: δ 2.50, pyridine: δ 8.74). Data are reported in table form as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants, and integration. 13 C NMR spectra were recorded on a Varian Unity 400 MHz spectrometer (100 MHz) with complete proton decoupling. Chemical shifts are reported in ppm from tetramethylsilane with the solvent resonance as the internal standard (CDCl 3 : δ 77.16, CD 3 OD: δ 49.00, DMSO: δ 39.52). Optical rotations were measured on a Perkin Elmer 241 Polarimeter. Unless otherwise noted, all solvents and reagents were purchased from VWR or Fisher and used without further purification. An anaerobic environment was achieved by three methods, and all were equally effective and used interchangeably: 1) Coy Laboratory Products anaerobic chamber; 2) BD GasPak TM EZ Gas Generating Container System; 3) Mitsubishi Gas Chemical Co. AnaeroPack TM System.
S1.2. Reagents used in immunology studies.
PBS-57 loaded mCD1d tetramers, which were used for mouse experiments, and unloaded mCD1d monomers were obtained from the NIH Tetramer Core Facility. For loading, monomers were incubated with KRN7000 or α-GalCer Bf diluted in DMSO at 6 fold molar excess at 37°C for 3 hrs in the presence of pepstatin, leupeptin, EDTA and Tween20. Samples were concentrated using a 30K microconcentrator. Monomers were tetramerized by incubation with strepavidin-conjugated APC (Molecular probes) at a 1:1 ratio. Staining was performed at room temperature for 1hr. CD4 (RM4-5), CD3 (2C11), CD69 (H1.2F3), CD25 (PC61), NK1.1 (PK136), CD86 (GL1), MHCII (NIMR-4), IFNγ (XMG1.2) were purchased (BioLegend, eBiosciences, SBA or Pharmingen). For cell surface staining, cells were preincubated with 2.4G2 culture supernatant (UCSF cell culture facility) and incubated with antibodies/tetramer for 30 minutes at 4 °C. Viability was determined by staining cells with LIVE/DEAD fixable Aqua stain (Invitrogen) per manufacturer's instructions. 200ug Anti-CD1d antibody (1B1 clone, eBiosciences) was administered i.v. 5-30 minutes prior to BMDC transfer. Rat IgG2b (LTF-2, UCSF cell culture facility) was used as isotype control. KRN7000 was purchased from Avanti Polar Lipids.
S1
.3. Bacterial Strains and Growth Conditions. B. fragilis NCTC 9343 was the type strain used in this study and was the parental strain of the deletion mutants. Bacteroides were grown anaerobically in basal medium or on brain-heart infusion plates supplemented with hemin (50 µg/ml) and vitamin K 1 (0.5 µg/ml) (BHIS plates), with gentamicin (200 µg/ml) and erythromycin (5 µg/ml) added where appropriate. E. coli DH5α containing recombinant plasmids was grown in L broth or on L agar plates containing kanamycin (50 µg/ml).
S1.4. Mice.
For in vivo activation of NKT cells, C57BL/6 female mice aged 6-12 weeks purchased from Jackson Laboratory (Bar Harbor, ME) were used. Mice were housed under specific pathogen-free conditions at the University of California, San Francisco Animal Barrier Facility and experiments were approved by the Institutional Animal Care and Use Committee of the University of California, San Francisco. S1.5. Bone Marrow-Derived Dendritic Cells. Bone marrow progenitors were cultured in IMDM containing 10% FBS with addition of 20 ng/ml GM-CSF (G6 supernatant, Abbas Laboratory) starting on day 2 and 1 ng/ml IL-4 (I3L6 supernatant, Abbas Laboratory) on day 6. For in vivo transfers and in vitro CD1d blocking experiments, BMDCs were pulsed with 1ng/mL LPS (Escherichia coli O26:B6; Sigma-Aldrich) +/-10 ug/mL α-GalCer Bf on day 8. After overnight culture, cells were harvested and washed twice before use.
S1.6. Statistical analysis.
The statistical significance of differences in Fig. 3f between each group and the "nothing" control was determined by the Wilcoxon matched-pairs signed rank test using Prism software. The statistical significance of differences between groups in Fig. 4g was determined by the Mann-Whitney test using Prism software.
S1.7. Construction of ∆BF2461 deletion mutant.
Creation of the deletion mutant involved PCR amplification of DNA flanking the each side of the region to be deleted, digestion of these products with restriction enzymes utilizing sites engineered into the primers (underlined below), and three-way ligation into SstI or BamHI site of the Bacteroides conjugal suicide vector pNJR6. The resulting plasmid in E. coli DH5α was conjugally transferred into B. fragilis and cointegrates were selected by Em r . Cointegrates were passaged, plated on nonselective medium, and replica plated to medium containing erythromycin. Em s colonies were screened by PCR to detect those acquiring the mutant genotype. The BF2461 deletion mutant was constructed so that 1,078 bp of the 1,185-bp gene was deleted. 
∆BF2461 -right flanking region -3' S1.8. Growth Measurements. B. fragilis NCTC 9343 and mutant strains were cultured by inoculating 100 mL basal medium with growth from a freshly inoculated BHIS plate to an OD 600 of 0.01. OD600 was recorded at regular intervals and CFU/mL was determined at each time point. S1.9. Purification of sphingolipids and free ceramide from B. fragilis NCTC 9343. B. fragilis NCTC 9343 was allowed to grow under an anaerobic atmosphere in basal medium (4.5 L) supplemented with hemin (50 µg/ml) and vitamin K 1 (0.5 µg/ml) at 37 ºC for 2d. The cells were harvested by centrifugation and extracted with CHCl 3 :MeOH (2:1, 1.5 L). The organic extract was filtered and concentrated, then re-dissolved in CHCl 3 :MeOH (2:1, 100 ml) and treated with NaOH (0.5 N, 100 ml). The suspension was allowed to stir at 37 ºC for 1 h, then brought to pH 2-4 with 10% HCl. The aqueous layer was extracted with CHCl 3 :MeOH (2:1, 3 x 500 ml). The organic layers were combined, dried (Na 2 SO 4 ), and concentrated to give 0.5 g crude extract. 72.23, 68.57, 61.22, 54.68, 43.34, 38.95, 37.05, 36.52, 34.30, 33.88, 31.80, 29.90, 29.81, 29.59, 29.56, 29.55, 29.52, 29.51, 29.48, 29.36, 29.23, 27.84, 27.29, 26.98, 25.79, 25.40, 22.53, 22.36 65, 69.69, 68.33, 64.26, 61.46, 53.95, 53.89, 43.28, 40.23, 40.16, 38.76, 37.01, 33.31, 31.61, 29.61, 29.38, 29.15, 29.03, 27.64, 27.09, 25.53, 25.28, 22.04 S6 S1.10. Semi-synthetic generation of α-GalCer Bf .
TMS-protected galactose 2 and α-iodo-substituted compound S1 3 were prepared as previously described. Ceramide (5.0 mg, 0.0088 mmol) was isolated from B. fragilis NCTC 9343 as described above. α-Selective glycosylation was carried out as previously described, and α-GalCer Bf was obtained after purification by preparative TLC as described above in 12% yield (0.74 mg, 0.0010 mmol). Unreacted ceramide was recovered in 52% after purification (2.6 mg, 0.0046 mmol). 1 H NMR analysis (600 MHz, DMSO) of semisynthetic α-GalCer Bf indicated that it was identical to α-GalCer Bf isolated from B. fragilis NCTC 9343.
S1.11. Methanolysis of ceramide and determination of absolute configuration.
Ceramide isolated from B. fragilis NCTC 9343 (10 mg, 0.018 mmol) was suspended in a solution of HCl in methanol (2 mL, 2N) in a sealed tube. 4 The mixture was kept at 100 ºC for 3 h, then allowed to cool to room temperature. Water (1mL) was added, after which the aqueous layer was washed with hexanes (3 x 3 mL). The aqueous layer was set aside. The organic layers were combined, dried over Na 2 SO 4 , and the volatiles were removed in vacuo. The resulting residue, which contained fatty acide methyl ester (FAME) S2, was purified by silica gel chromatography (10:1 hexanes:EtOAc) to furnish pure S2 (2.8 mg, 0.0092 mmol, 51%). The aqueous layer was treated with concentrated KOH until a pH of 10-12 was reached, then washed with Et 2 O (2 x 2 mL). The organic layers were combined, dried over Na 2 SO 4 , and the volatiles were removed in vacuo. The resulting residue, which contained long chain base (LCB) S3, was purified by preparative TLC (silica gel, 100:20:12:5 CHCl 3 :MeOH:AcOH:H 2 O, R f = 0.37) to furnish pure S3 (1.1 mg, 0.0038 mmol, 21%). 4.11 (dd, J = 10.4, 7.3 Hz, 1H), 1H), 1H) 
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